Janumet and Premarin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Janumet (metformin hydrochloride; sitagliptin phosphate) and Premarin (estrogens, conjugated). Common drug interactions include anxiety among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Janumet and Premarin. It is created by eHealthMe based on reports of 81 people who take the same drugs from the FDA, and is updated regularly.

What is Janumet?

Janumet has active ingredients of metformin hydrochloride; sitagliptin phosphate. It is often used in diabetes. eHealthMe is studying from 25,023 Janumet users. Check the latest studies of Janumet.

What is Premarin?

Premarin has active ingredients of estrogens, conjugated. It is often used in hormone replacement therapy. eHealthMe is studying from 99,630 Premarin users. Check the latest studies of Premarin.



On Jul, 26, 2026

81 people who take Janumet and Premarin together, and have interactions are studied.

Janumet and Premarin drug interactions.

What are the common drug interactions of Janumet and Premarin, by gender? *:

female:

  1. Anxiety
  2. Asthenia (weakness)
  3. Blindness
  4. Blood pressure increased
  5. Body temperature increased
  6. Chronic kidney disease
  7. Renal failure (kidney dysfunction)
  8. Pancreatitis acute (sudden inflammation of pancreas)
  9. Drug ineffective
  10. Dyspnoea (difficult or laboured respiration)

male:

  1. Chronic kidney disease
  2. Blood glucose increased
  3. Septic shock (shock due to blood infection)
  4. Thrombosis (formation of a blood clot inside a blood vessel)
  5. Visual impairment
  6. Vitreous floaters (spots before the eyes)
  7. Weight decreased
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  9. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
  10. Memory impairment

What are the common drug interactions of Janumet and Premarin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Ovarian vein thrombosis (clot formation in ovary vein)
  2. Pelvic venous thrombosis (blood clot occurring inside a blood vessel and thromboses (dvts) that form in the deep veins of the legs or in the pelvic veins)

40-49:

  1. Burning sensation
  2. Eye disorder
  3. Thyroid neoplasm (tumour of thyroid)
  4. Visual acuity reduced (reduced clearness of vision)
  5. Chronic kidney disease
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  7. Nephrogenic anaemia (anaemia due to kidney disease)
  8. Papillary thyroid cancer
  9. Renal failure (kidney dysfunction)

50-59:

  1. Renal failure (kidney dysfunction)
  2. Retinal tear
  3. Thrombosis (formation of a blood clot inside a blood vessel)
  4. Visual impairment
  5. Vitreous floaters (spots before the eyes)
  6. Weight decreased
  7. Drug ineffective
  8. Hypertension (high blood pressure)
  9. Memory impairment
  10. Gait disturbance

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Platelet count increased
  4. Pulmonary oedema (fluid accumulation in the lungs)
  5. Renal tubular necrosis (death of kidney tubules)
  6. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
  7. Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
  8. Vomiting
  9. Adrenal adenoma (benign tumour of the glandular type (adenoma) in the adrenal gland)
  10. Back pain

What are the existing conditions these people have? *

  1. High Blood Pressure: 19 people, 23.46%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 18 people, 22.22%
  3. Depression: 16 people, 19.75%
  4. High Blood Cholesterol: 14 people, 17.28%
  5. Pain: 13 people, 16.05%
  6. Type 2 Diabetes: 12 people, 14.81%
  7. Stress And Anxiety: 12 people, 14.81%
  8. Indigestion: 11 people, 13.58%
  9. Blood Pressure Abnormal: 11 people, 13.58%
  10. Muscle Spasms (muscle contraction): 11 people, 13.58%

* Approximation only. Some reports may have incomplete information.

Do you take Janumet and Premarin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Janumet and Premarin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Janumet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Premarin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Janumet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Premarin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on metformin hydrochloride; sitagliptin phosphate and estrogens, conjugated (the active ingredients of Janumet and Premarin, respectively), and Janumet and Premarin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: